CD11ahigh was highest in the CD28− T-cell subset in peripheral blood, however a dramatic decline was observed within both subsets with the transition to the tumor site (Fig. 4B), where the CD28+ T-cell subgroup showed highest expression (Fig. 4C). The gene discussed is CD28; the disease is neoplasm.